KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Return on Equity: 2021-2025

Historic Return on Equity for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to -0.58%.

  • Ginkgo Bioworks Holdings' Return on Equity rose 22.00% to -0.58% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.58%, marking a year-over-year increase of 22.00%. This contributed to the annual value of -0.60% for FY2024, which is 3.00% up from last year.
  • Ginkgo Bioworks Holdings' Return on Equity amounted to -0.58% in Q3 2025, which was down 15.78% from -0.50% recorded in Q2 2025.
  • Ginkgo Bioworks Holdings' Return on Equity's 5-year high stood at -0.28% during Q3 2021, with a 5-year trough of -2.35% in Q3 2022.
  • For the 3-year period, Ginkgo Bioworks Holdings' Return on Equity averaged around -0.75%, with its median value being -0.76% (2023).
  • In the last 5 years, Ginkgo Bioworks Holdings' Return on Equity tumbled by 206bps in 2022 and then soared by 173bps in 2023.
  • Ginkgo Bioworks Holdings' Return on Equity (Quarterly) stood at -1.15% in 2021, then dropped by 17bps to -1.32% in 2022, then spiked by 56bps to -0.76% in 2023, then increased by 4bps to -0.72% in 2024, then rose by 22bps to -0.58% in 2025.
  • Its Return on Equity was -0.58% in Q3 2025, compared to -0.50% in Q2 2025 and -0.69% in Q1 2025.